Skip to main content

Table 1 Comparison of general demographic features and lipid profiles between patients with coronary heart disease (CHD) and healthy controls (control)

From: Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China

Characteristic

CHD (n = 238)

Control (n = 236)

t (χ2)

P-value

Nationality (Li/Han)

112/126

120/116

0.681

0.409

Sex (male/female)

138/100

119/117

2.728

0.099

Age (years)

62.56 ± 12.34

60.76 ± 11.04

1.674

0.095

Systolic pressure (mmHg)

134.07 ± 21.54**

128.50 ± 14.61

29.204

0.000

Diastolic pressure (mmHg)

78.94 ± 11.71**

77.56 ± 7.87

13.18

0.000

Non-smoker/smoker

77/161

59/177

3.131

0.077

Non-drinker/drinker

46/192

63/173

3.632

0.057

FBS (mmol/L)

5.92 ± 1.51**

5.65 ± 0.47

2.66

0.008

TC (mmol/L)

4.95 ± 0.96*

4.79 ± 0.75

2.024

0.044

TG (mmol/L)

1.47 ± 1.05**

1.18 ± 0.73

3.542

0.000

HDL-C (mmol/L)

1.06 ± 0.34**

1.28 ± 0.30

−7.441

0.000

LDL-C (mmol/L)

3.08 ± 0.83**

2.82 ± 0.72

3.709

0.000

ApoAI (g/L)

1.16 ± 0.36**

1.32 ± 0.35

−4.936

0.000

ApoB (g/L)

1.04 ± 0.24**

0.87 ± 0.17

8.732

0.000

Lp(a) (mg/L)

257.41 ± 189.07*

217.44 ± 165.27

2.451

0.015

  1. Data are expressed as mean ± SD. FBS Fasting blood sugar, TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, ApoAI Lipoprotein AI, ApoB Lipoprotein B; Lp(a) Lipoprotein a, CHD Coronary heart disease. *P < 0.05, **P < 0.01, CHD patients versus healthy controls using χ2 test or t-test
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X